SI2857019T1 - Postopek zdravljenja multiple skleroze - Google Patents
Postopek zdravljenja multiple sklerozeInfo
- Publication number
- SI2857019T1 SI2857019T1 SI201331768T SI201331768T SI2857019T1 SI 2857019 T1 SI2857019 T1 SI 2857019T1 SI 201331768 T SI201331768 T SI 201331768T SI 201331768 T SI201331768 T SI 201331768T SI 2857019 T1 SI2857019 T1 SI 2857019T1
- Authority
- SI
- Slovenia
- Prior art keywords
- multiple sclerosis
- treating multiple
- treating
- sclerosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1257254A FR2993780B1 (fr) | 2012-07-26 | 2012-07-26 | Methode de traitement de la sclerose en plaque |
| US13/644,615 US8835487B2 (en) | 2012-07-26 | 2012-10-04 | Method of treating multiple sclerosis |
| EP14194213.6A EP2857019B1 (en) | 2012-07-26 | 2013-04-29 | Method of treating multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2857019T1 true SI2857019T1 (sl) | 2020-10-30 |
Family
ID=47294963
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201331768T SI2857019T1 (sl) | 2012-07-26 | 2013-04-29 | Postopek zdravljenja multiple skleroze |
| SI201330023T SI2729143T1 (sl) | 2012-07-26 | 2013-04-29 | Uporaba biotina za zdravljenje multiple skleroze |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201330023T SI2729143T1 (sl) | 2012-07-26 | 2013-04-29 | Uporaba biotina za zdravljenje multiple skleroze |
Country Status (25)
| Country | Link |
|---|---|
| US (5) | US8835487B2 (sl) |
| EP (2) | EP2857019B1 (sl) |
| JP (1) | JP6208235B2 (sl) |
| KR (1) | KR101967502B1 (sl) |
| CN (2) | CN104602689A (sl) |
| AU (1) | AU2013295370B2 (sl) |
| BR (1) | BR112015001562A2 (sl) |
| CA (1) | CA2879434C (sl) |
| CY (1) | CY1116304T1 (sl) |
| DK (2) | DK2729143T3 (sl) |
| EA (1) | EA030478B1 (sl) |
| ES (3) | ES2532364T3 (sl) |
| FR (1) | FR2993780B1 (sl) |
| HK (1) | HK1207583A1 (sl) |
| HR (1) | HRP20150260T1 (sl) |
| HU (1) | HUE024558T2 (sl) |
| IL (1) | IL236790A (sl) |
| LT (1) | LT2857019T (sl) |
| ME (1) | ME02060B (sl) |
| PL (1) | PL2729143T3 (sl) |
| PT (2) | PT2857019T (sl) |
| RS (1) | RS53893B1 (sl) |
| SI (2) | SI2857019T1 (sl) |
| SM (1) | SMT201500057B (sl) |
| WO (1) | WO2014016003A1 (sl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2993780B1 (fr) | 2012-07-26 | 2015-02-13 | Assist Publ Hopitaux De Paris | Methode de traitement de la sclerose en plaque |
| FR2958166B1 (fr) * | 2010-04-06 | 2012-07-13 | Assist Publ Hopitaux De Paris | Compositions pharmaceutiques fortement dosees en biotine |
| US9789092B2 (en) | 2013-04-29 | 2017-10-17 | Assistance Publique—Hopitaux de Paris | Biotin for use in treating X-linked adrenoleukodystrophy |
| JP6108045B2 (ja) * | 2015-02-13 | 2017-04-05 | ユニマテック株式会社 | 含フッ素共重合体およびこれを有効成分とする表面改質剤 |
| EP3072513A1 (en) | 2015-03-26 | 2016-09-28 | Medday | Biotin for treating Amyotrophic lateral sclerosis |
| US20170135969A1 (en) | 2015-11-12 | 2017-05-18 | Jds Therapeutics, Llc | Topical arginine-silicate-inositol for wound healing |
| RU2638803C2 (ru) * | 2016-06-09 | 2017-12-15 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Таблетки биотина с замедленным высвобождением и способ их получения |
| RU2611415C1 (ru) * | 2015-11-17 | 2017-02-21 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ ТЕРАПЕВТИЧЕСКИМ ЭФФЕКТОМ В ОТНОШЕНИИ ДЕМИЕЛИНИЗИРУЮЩИХ ЗАБОЛЕВАНИЙ (Варианты) |
| WO2017086835A1 (ru) * | 2015-11-17 | 2017-05-26 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Фармацевтическая композиция, обладающая терапевтическим эффектом в отношении демиелинизирующих заболеваний (варианты) |
| EP3275439A1 (en) | 2016-07-29 | 2018-01-31 | Medday Pharmaceuticals | Method for treating hepatic encephalopathy |
| CA3035584A1 (en) * | 2016-09-01 | 2018-03-08 | Jds Therapeutics, Llc | Magnesium biotinate compositions and methods of use |
| RU2639488C1 (ru) * | 2017-04-06 | 2017-12-21 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Фармацевтическая композиция, содержащая биотин, и способ ее получения |
| US20200155510A1 (en) * | 2018-11-13 | 2020-05-21 | Jds Therapeutics, Llc | Treatment of autoimmune disorders, such as relapsing remitting multiple sclerosis and clinically isolated syndrome with biotin compositions |
| CN112076310A (zh) * | 2019-06-14 | 2020-12-15 | 苏州融析生物科技有限公司 | 一种治疗多发性硬化的药物组合物及其制备 |
| GB2613672A (en) | 2019-12-16 | 2023-06-14 | Nutrition 21 Llc | Methods of production of aginine-silicate complexes |
| CA3157712C (en) | 2020-01-01 | 2024-01-23 | Jotiram PALKAR | Synergistic nutritional compositions for enhancing atp efficiency |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3609165A (en) | 1968-07-19 | 1971-09-28 | Research Corp | 1,3-diazabicyclo {8 3.1.0{9 {0 hex-3-enes |
| JPH0995448A (ja) | 1995-09-29 | 1997-04-08 | Calpis Food Ind Co Ltd:The | 血中ビオチン濃度の増加方法およびビオチン含有飲食品 |
| EP0891719A1 (en) * | 1997-07-14 | 1999-01-20 | N.V. Nutricia | Nutritional composition containing methionine |
| US5789401A (en) | 1997-08-08 | 1998-08-04 | Nutrition 21 | High-dose chromium/biotin treatment of type II diabetes |
| US6664039B1 (en) | 1998-10-14 | 2003-12-16 | California Institute Of Technology | Methods and compositions for modulating neurodegeneration |
| UA73492C2 (en) * | 1999-01-19 | 2005-08-15 | Aromatic heterocyclic compounds as antiinflammatory agents | |
| DE19903241A1 (de) | 1999-01-28 | 2000-08-03 | Merck Patent Gmbh | Galenische Formulierung |
| US20050256178A1 (en) | 2002-08-23 | 2005-11-17 | Eggersdorfer Manfred L | Novel nutraceutical compositions comprising boitin |
| EP1547584B1 (en) | 2002-09-30 | 2010-06-30 | Daiichi Pharmaceutical Co., Ltd. | Particulate product comprising pantethine |
| DE10341240A1 (de) * | 2003-09-08 | 2005-04-07 | Aventis Pharma Deutschland Gmbh | Substituierte Thienoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| AU2003300167B2 (en) * | 2003-12-31 | 2010-09-16 | K-Pax Vitamins, Inc. | Nutrient compositions and methods for enhanced effectiveness of the immune system |
| IL162288A0 (en) * | 2004-06-01 | 2005-11-20 | Future Products Man S A | Compositions and methods for treating neurodegenerative disorders |
| BG66011B1 (bg) * | 2005-05-25 | 2010-10-29 | Райна Щонова | Състав от растителен произход |
| EP2515863A2 (en) | 2009-12-23 | 2012-10-31 | Lupin Limited | Slow release pharmaceutical compositions of iloperidone |
| FR2993780B1 (fr) | 2012-07-26 | 2015-02-13 | Assist Publ Hopitaux De Paris | Methode de traitement de la sclerose en plaque |
| FR2958166B1 (fr) * | 2010-04-06 | 2012-07-13 | Assist Publ Hopitaux De Paris | Compositions pharmaceutiques fortement dosees en biotine |
-
2012
- 2012-07-26 FR FR1257254A patent/FR2993780B1/fr not_active Expired - Fee Related
- 2012-10-04 US US13/644,615 patent/US8835487B2/en active Active
-
2013
- 2013-04-29 KR KR1020157004516A patent/KR101967502B1/ko active IP Right Grant
- 2013-04-29 CA CA2879434A patent/CA2879434C/en not_active Expired - Fee Related
- 2013-04-29 EP EP14194213.6A patent/EP2857019B1/en active Active
- 2013-04-29 PT PT141942136T patent/PT2857019T/pt unknown
- 2013-04-29 EP EP13719836.2A patent/EP2729143B1/en active Active
- 2013-04-29 CN CN201380039687.3A patent/CN104602689A/zh active Pending
- 2013-04-29 WO PCT/EP2013/058936 patent/WO2014016003A1/en active Application Filing
- 2013-04-29 ES ES13719836.2T patent/ES2532364T3/es active Active
- 2013-04-29 SI SI201331768T patent/SI2857019T1/sl unknown
- 2013-04-29 PT PT13719836T patent/PT2729143E/pt unknown
- 2013-04-29 CN CN201910026016.2A patent/CN109908140A/zh active Pending
- 2013-04-29 LT LTEP14194213.6T patent/LT2857019T/lt unknown
- 2013-04-29 ES ES14194213T patent/ES2811074T3/es active Active
- 2013-04-29 DK DK13719836.2T patent/DK2729143T3/en active
- 2013-04-29 HU HUE13719836A patent/HUE024558T2/hu unknown
- 2013-04-29 DK DK14194213.6T patent/DK2857019T3/da active
- 2013-04-29 JP JP2015523453A patent/JP6208235B2/ja not_active Expired - Fee Related
- 2013-04-29 RS RS20150168A patent/RS53893B1/en unknown
- 2013-04-29 PL PL13719836T patent/PL2729143T3/pl unknown
- 2013-04-29 BR BR112015001562A patent/BR112015001562A2/pt not_active Application Discontinuation
- 2013-04-29 ME MEP-2015-32A patent/ME02060B/me unknown
- 2013-04-29 SI SI201330023T patent/SI2729143T1/sl unknown
- 2013-04-29 AU AU2013295370A patent/AU2013295370B2/en not_active Ceased
- 2013-04-29 EA EA201590270A patent/EA030478B1/ru not_active IP Right Cessation
-
2014
- 2014-01-14 ES ES14700423.8T patent/ES2626079T3/es active Active
- 2014-08-13 US US14/458,625 patent/US9351961B2/en active Active
-
2015
- 2015-01-19 IL IL236790A patent/IL236790A/en active IP Right Grant
- 2015-03-09 HR HRP20150260TT patent/HRP20150260T1/hr unknown
- 2015-03-09 SM SM201500057T patent/SMT201500057B/xx unknown
- 2015-03-11 CY CY20151100243T patent/CY1116304T1/el unknown
- 2015-08-27 HK HK15108330.5A patent/HK1207583A1/xx unknown
-
2016
- 2016-04-12 US US15/096,957 patent/US10201528B2/en not_active Expired - Fee Related
-
2018
- 2018-12-21 US US16/231,111 patent/US20190117626A1/en not_active Abandoned
- 2018-12-21 US US16/231,073 patent/US20190117625A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2857019T (pt) | Método de tratamento de esclerose múltipla | |
| IL237791B (en) | A method for treating cancer | |
| HK1219414A1 (zh) | 治療關節炎的方法 | |
| EP2773754A4 (en) | Methods of Treatment | |
| GB201110095D0 (en) | Method of treatment | |
| SG11201503893RA (en) | Method of treating cancer | |
| ZA201408342B (en) | Method of treating hair | |
| ZA201408353B (en) | Method of treating hair | |
| EP2892536A4 (en) | METHOD FOR TREATING LEUKEMIA | |
| EP2758780A4 (en) | METHOD OF TREATING MULTIPLE SCLEROSIS | |
| ZA201408343B (en) | Method of treating hair | |
| EP2895206A4 (en) | METHOD FOR TREATING CARCINOMA | |
| EP2884975A4 (en) | METHOD OF TREATING ONYCHOMYCOSIS | |
| EP2814479A4 (en) | METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS | |
| EP2531259A4 (en) | METHOD FOR TREATING MULTIPLE SCLEROSIS | |
| HK1206649A1 (en) | Method of treating acne acne | |
| GB201215942D0 (en) | Method of treatent | |
| EP2800763A4 (en) | COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS | |
| EP2791324A4 (en) | PROCESSING METHOD | |
| GB201221032D0 (en) | Method of treatment | |
| GB201207894D0 (en) | Method of treatment | |
| GB201321600D0 (en) | Method of cleaning | |
| GB201221118D0 (en) | Methods of treatment | |
| GB201216748D0 (en) | Methods of treatment | |
| GB201216740D0 (en) | Methods of treatment |